Healthcare entity
Every one of those 1 sits in a single category, health-it. LivePerson is most often covered alongside Bakkt, which appears in 1 of these 1 story. Each story carries 3 original sources on average, compared with 2.5 for the broader beat in this window.
Last mentioned: Mar 18, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 1 sits in a single category, health-it. LivePerson is most often covered alongside Bakkt, which appears in 1 of these 1 story. Each story carries 3 original sources on average, compared with 2.5 for the broader beat in this window. The 6 average consequence score is above the beat benchmark of 5.8 in the same window. We currently track 1 Healthcare story that mention LivePerson, all published on March 18, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 24 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering LivePerson. Shared-story counts are live from our verified record — not editorial picks.
PDUFA Date
Target date for FDA decision on INO-3107 accelerated approval.
Platform Modernization
LivePerson expects to complete its multiyear platform modernization.
BLA Acceptance
FDA accepts Inovio's BLA for INO-3107 under accelerated approval program.
Inovio Cash Position
Company ends the year with $94.1 million in cash.
Inovio Pharmaceuticals faces a critical regulatory juncture as the FDA accepts its BLA for INO-3107 while questioning its accelerated approval eligibility. Meanwhile, LivePerson is pivoting toward a unified AI architecture with the launch of its Syntrix platform, signaling a shift in how healthcare enterprises may manage patient engagement.
Source: Motley Fool Transcribing (us) · Motley Fool Transcribing (us)
LivePerson is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
